{
    "code": "02023469",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023469",
    "time": "2020-02-25 13:08:18",
    "許可證字號": "衛署藥輸字第023469號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/05\/31",
    "註銷理由": "許可證已逾有效期",
    "有效日期": "101\/06\/18",
    "發證日期": "91\/06\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202346907",
    "中文品名": "哲思膠囊２０公絲",
    "英文品名": "GEODON CAPSULES 20MG",
    "適應症": "精神分裂症、雙極性疾患之躁症發作及在雙極性疾患躁症發作(Bipolar I disorder)之維持治療中作為鋰鹽或valproate的輔助療法。",
    "劑型": "130膠囊劑",
    "包裝": "2-1000粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
        "申請商地址": "新北市淡水區中正東路二段１７７號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "Z102100909",
            "成分名稱": "ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE",
            "含量描述": "",
            "含量": "22.6500000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020234690014___20110128.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023469&Seq=016&Type=9"
        }
    ]
}